NEK2 Human Pre-designed siRNA Set A contains three designed siRNAs for NEK2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NEK3 Human Pre-designed siRNA Set A contains three designed siRNAs for NEK3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NEK4 Human Pre-designed siRNA Set A contains three designed siRNAs for NEK4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NEK5 Human Pre-designed siRNA Set A contains three designed siRNAs for NEK5 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NEK6 Human Pre-designed siRNA Set A contains three designed siRNAs for NEK6 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NEK7 Human Pre-designed siRNA Set A contains three designed siRNAs for NEK7 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NEK8 Human Pre-designed siRNA Set A contains three designed siRNAs for NEK8 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NEK9 Human Pre-designed siRNA Set A contains three designed siRNAs for NEK9 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NELFA Human Pre-designed siRNA Set A contains three designed siRNAs for NELFA gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NELFB Human Pre-designed siRNA Set A contains three designed siRNAs for NELFB gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NELFE Human Pre-designed siRNA Set A contains three designed siRNAs for NELFE gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Nelfinavir-d4 is deuterated labeled Nelfinavir (HY-15287). Nelfinavir (AG-1341) is a potent and orally bioavailable HIV-1 protease inhibitor (Ki=2 nM) for HIV infection. Nelfinavir is a broad-spectrum, anticancer agent[1][2][3].

NELL1 Human Pre-designed siRNA Set A contains three designed siRNAs for NELL1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NELL2 Human Pre-designed siRNA Set A contains three designed siRNAs for NELL2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NEMF Human Pre-designed siRNA Set A contains three designed siRNAs for NEMF gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NEMP1 Human Pre-designed siRNA Set A contains three designed siRNAs for NEMP1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NENF Human Pre-designed siRNA Set A contains three designed siRNAs for NENF gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NEO1 Human Pre-designed siRNA Set A contains three designed siRNAs for NEO1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Neoastragaloside I (Compound 20) is a compound that can be isolated from Radix Astragali.

Neocryptolepine (Cryptotackieine) has antiplasmodial activity. Neocryptolepine also shows antibacterial activity against Gram-positive bacteria (MIC < 100 μg/mL), and antifungal activity[1][2].

Neodidymelliosides A (compound 1)It is a secondary metabolite of fungi and has a significant inhibitory effect on Staphylococcus aureus and Candida albicans biofilms. Neodidymelliosides AIt also has anti-cancer activity and can inhibit KB3.1 (cervix),PC-3 (prostate),MCF-7(breast),SKOV-3 (ovary),A431 (skin )and A549 (lung )Cell viability of cell lines[1].

Neopetromin is a tripeptide with a rare heteroaromatic C-N cross-link between side chains of tryptophan and tyrosine. Neopetromin causes vacuole fragmentation in an actin-independent manner[1].

Neotame (Standard) is the analytical standard of Neotame. This product is intended for research and analytical applications. Neotame is a derivative of Aspartame and is a low-caloric and high-intensity artificial sweetener that is 7000-13,000 times sweeter than sugar. Neotame is a non-nutritive sweetener and flavor enhancer that can be used in a variety of foods[1][2].

Neplanocin A ((-)-Neplanocin A) is an antitumor antibiotic with significant antitumor activity against murine L1210 leukemia. Neplanocin A is also an irreversible inhibitor of AdoHcy hydrolase (Ki=8.39 nM). Neplanocin A also has antiviral activity and is effective against vaccinia virus. Neplanocin A is obtained from Ampulariella regularis[1].

NEPRO Human Pre-designed siRNA Set A contains three designed siRNAs for NEPRO gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Nerol-d2 is deuterated labeled Octanal (HY-N8015). Octanal is an aromatic aldehyde, with antioxidant and antimicrobial activities. Octanal shows cytotoxicity against Hela cells[1].

Nerol-d6 is deuterated labeled Oct-1-en-3-ol (HY-W010410). Oct-1-en-3-ol, a fatty acid fragrant, is a self-stimulating oxylipin messenger. Oct-1-en-3-ol serves as a signaling molecule in plant cellular responses, plant-herbivore interactions, and plant-plant interactions. Oct-1-en-3-ol causes dopamine neuron degeneration through disruption of dopamine handling[1][2].

Nerolidol-d4 is deuterated labeled Tenuazonic acid (HY-N6715). Tenuazonic acid, belonging to tetramic acids that are the largest family of natural products, is a putative nonhost-selective mycotoxin isolated from Alternaria alternate[1]. Tenuazonic acid blocks electron transport beyond primary quinone acceptor (QA) by interacting with D1 protein and it is a broad-spectrum and effective photosystem II (PSII) […]

Nervonoyl ethanolamide (NEA) is an endogenous cannabinoid that can act as a presynaptic and postsynaptic neuromodulator. Nervonoyl ethanolamide can also be used in the research of inflammation[1].

NES Human Pre-designed siRNA Set A contains three designed siRNAs for NES gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NET1 Human Pre-designed siRNA Set A contains three designed siRNAs for NET1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NETO1 Human Pre-designed siRNA Set A contains three designed siRNAs for NETO1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NETO2 Human Pre-designed siRNA Set A contains three designed siRNAs for NETO2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NEU1 Human Pre-designed siRNA Set A contains three designed siRNAs for NEU1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NEU2 Human Pre-designed siRNA Set A contains three designed siRNAs for NEU2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NEU3 Human Pre-designed siRNA Set A contains three designed siRNAs for NEU3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NEU4 Human Pre-designed siRNA Set A contains three designed siRNAs for NEU4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Neuraminidase-IN-17 (compound N10) is a neuraminidase inhibitor with the EC50 of 0.11 μM. Neuraminidase-IN-17 shows antiviral activity in vitro[1].

Neuraminidase-IN-18 (compound N5) is a novel polyheterocyclic neuraminidase (NA) inhibitor. Neuraminidase-IN-18 shows potency in inhibition of H5N1 NA with an IC50 of 0.14 μM and 0.27 μM against the wild-type H5N1 NA and H5N1-H274Y mutant NA, respectively. Neuraminidase-IN-18 inhibits influenza virus replication by binding to NAs in cell level[1].